Since its beginnings, the EuroEspes Group been involved with projects for the development of its own R&D&I, the objective being to optimise human health through products and services oriented towards predictive medicine and its preventive applications.
The EuroEspes Group continually invests in the research and development of new products. A fundamental area of this being the undertaking of internationally recognised and endorsed scientific studies to demonstrate their beneficial effects on human and animal health.
Special mention should be made of the work carried out to date in marine bioprospecting, based on research into active compounds from marine species that are susceptible to development into nutraceuticals. Apart from this, the work carried out by the health biotechnology unit, which carries out intense research focused on diseases of the central nervous system, is also worth highlighting.
International recognition is evident through the EuroEspes Group's participation in various national and international collaborative research projects, as well as in scientific results published in prestigious international journals.
Likewise, EuroEspes also participates in various entities, such as clusters or associations, whose objective is to respond to sectoral problems, as well as to promote competitiveness and innovation among its members.
Among the entities in which EuroEspes actively participates we can highlight:
Development of pharmacogenetic profiles of therapeutic utility in pathologies of the central nervous system.